Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Accumulated Expenses (2016 - 2026)

Phibro Animal Health has reported Accumulated Expenses over the past 13 years, most recently at $128.4 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 269.79% year-over-year to $128.4 million; the TTM value through Dec 2025 reached $128.4 million, up 269.79%, while the annual FY2025 figure was $51.8 million, 41.7% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $128.4 million at Phibro Animal Health, up from $20.8 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $128.4 million in Q4 2025 and troughed at $735000.0 in Q2 2021.
  • A 5-year average of $51.0 million and a median of $51.8 million in 2025 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 4563.67% in 2022 and later plummeted 82.98% in 2023.
  • Year by year, Accumulated Expenses stood at $72.8 million in 2021, then dropped by 1.62% to $71.7 million in 2022, then increased by 5.05% to $75.3 million in 2023, then plummeted by 53.86% to $34.7 million in 2024, then surged by 269.79% to $128.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for PAHC at $128.4 million in Q4 2025, $20.8 million in Q3 2025, and $51.8 million in Q2 2025.